Nervgen Pharma Corp (NGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Operating Expenses | 8,810 | 5,490 | 4,590 | 4,479 | 4,677 |
| Operating Income | -8,810 | -5,490 | -4,590 | -4,479 | -4,677 |
| Other Income | -12,294 | 4,269 | -14,636 | 1,462 | -1,905 |
| Pre-tax Income | -21,104 | -1,221 | -19,226 | -3,017 | -6,582 |
| Net Income Continuous | -21,104 | -1,221 | -19,226 | -3,017 | -6,582 |
| Net Income | $-21,104 | $-1,221 | $-19,226 | $-3,017 | $-6,582 |
| EPS Basic Total Ops | -0.23 | -0.01 | -0.26 | -0.04 | -0.09 |
| EPS Basic Continuous Ops | -0.23 | -0.02 | -0.26 | -0.04 | -0.09 |
| EPS Diluted Total Ops | -0.27 | -0.07 | -0.26 | -0.04 | -0.09 |
| EPS Diluted Continuous Ops | -0.23 | -0.02 | -0.26 | -0.04 | -0.09 |
| EPS Diluted Before Non-Recurring Items | -0.37 | -0.09 | N/A | N/A | N/A |
| EBITDA(a) | $-8,800 | $-5,480 | $-4,580 | $-4,469 | $-4,667 |